223 results on '"Moreau-Gaudry, François"'
Search Results
2. Resveratrol and capsaicin as safer radiosensitizers for colorectal cancer compared to 5-fluorouracil
3. CRISPR editing to mimic porphyria combined with light: A new preclinical approach for prostate cancer
4. Differential Uridyl-diphosphate-Glucuronosyl Transferase 1A enzymatic arsenal explains the specific cytotoxicity of resveratrol towards tumor colorectal cells
5. Iron chelation rescues hemolytic anemia and skin photosensitivity in congenital erythropoietic porphyria
6. Mutation-Specific Guide RNA for Compound Heterozygous Porphyria On-target Scarless Correction by CRISPR/Cas9 in Stem Cells
7. CD63-GPC1-Positive Exosomes Coupled with CA19-9 Offer Good Diagnostic Potential for Resectable Pancreatic Ductal Adenocarcinoma
8. Generation of induced pluripotent stem cells-derived hepatocyte-like cells for ex vivo gene therapy of primary hyperoxaluria type 1
9. Combination treatment of resveratrol and capsaicin radiosensitizes pancreatic tumor cells by unbalancing DNA repair response to radiotherapy towards cell death
10. Resveratrol and capsaicin used together as food complements reduce tumor growth and rescue full efficiency of low dose gemcitabine in a pancreatic cancer model
11. Specific High-Sensitivity Enzymatic Reporter UnLOCKing-Mediated Detection of Oncogenic BCR::ABL1 and EGFR Rearrangements
12. Bioactive food components for colorectal cancer prevention and treatment: A good match.
13. Metabolic Correction of Congenital Erythropoietic Porphyria with iPSCs Free of Reprogramming Factors
14. An Orthotopic Model of Glioblastoma Is Resistant to Radiodynamic Therapy with 5-AminoLevulinic Acid
15. Neonatal bone marrow transplantation prevents liver disease in a murine model of erythropoietic protoporphyria
16. Differential Uridyl-diphosphate-Glucuronosyl Transferase 1A enzymatic arsenal explains the specific cytotoxicity of resveratrol towards tumor colorectal cells
17. Bioactive food components for colorectal cancer prevention and treatment: A good match
18. ON-Target Adverse Events of CRISPR-Cas9 Nuclease: More Chaotic than Expected
19. Analysis of Post-transcriptional Regulations by a Functional, Integrated, and Quantitative Method
20. Effective Gene Therapy of Mice with Congenital Erythropoietic Porphyria Is Facilitated by a Survival Advantage of Corrected Erythroid Cells
21. Recent progress in genome editing for gene therapy applications: the French perspective
22. Circulating Tumor Cell Clusters: United We Stand Divided We Fall
23. Cellular and Gene Therapy for Erythropoietic Porphyrias
24. Murine Retroviral but not Human Cellular Promoters Induce In Vivo Erythroid-specific Deregulation that can be Partially Prevented by Insulators
25. Covichem: A biochemical severity risk score of COVID-19 upon hospital admission
26. Next-Generation Cancer Biomarkers: Extracellular Vesicle DNA as a Circulating Surrogate of Tumor DNA
27. Genetic background influences hepcidin response to iron imbalance in a mouse model of hemolytic anemia (Congenital erythropoietic porphyria)
28. Targeted gene therapy in human-induced pluripotent stem cells from a patient with primary hyperoxaluria type 1 using CRISPR/Cas9 technology
29. Ultrasound-Induced Expression of a Heat Shock Promoter-Driven Transgene Delivered in the Kidney by Genetically Modified Mesenchymal Stem Cells
30. Congenital Erythropoietic Porphyria
31. Overexpression and role of the ATPase and putative DNA helicase RuvB-like 2 in human hepatocellular carcinoma
32. Porphyrias: Animal models and prospects for cellular and gene therapy
33. Self-Inactivating Lentiviral Vectors Resist Proviral Methylation but Do Not Confer Position-Independent Expression in Hematopoietic Stem Cells
34. MDR1 gene overexpression confers resistance to imatinib mesylate in leukemia cell line models
35. A SIN lentiviral vector containing piga cdna allows long-term phenotypic correction of CD34+-derived cells from patients with paroxysmal nocturnal hemoglobinuria
36. In vivo gene transfer targeting in pancreatic adenocarcinoma with cell surface antigens
37. High Clinical Value of Liquid Biopsy to Detect Circulating Tumor Cells and Tumor Exosomes in Pancreatic Ductal Adenocarcinoma Patients Eligible for Up-Front Surgery
38. Tumor‐proximal liquid biopsy to improve diagnostic and prognostic performances of circulating tumor cells
39. High-level erythroid-specific gene expression in primary human and murine hematopoietic cells with self-inactivating lentiviral vectors
40. Gene Therapy of a Mouse Model of Protoporphyria with a Self-Inactivating Erythroid-Specific Lentiviral Vector without Preselection
41. Correction of Deficient CD34+ Cells from Peripheral Blood after Mobilization in a Patient with Congenital Erythropoietic Porphyria
42. CRISPR-Cas9 genome editing induces megabase-scale chromosomal truncations
43. Are extracellular vesicles able to control human pluripotent stem cell fate?
44. Comparative analysis of Circulating Tumour Cells detection and circulating tumor DNA in liquid biopsy for the diagnosis of early stage pancreatic adenocarcinoma
45. Correction of Uroporphyrinogen Decarboxylase Deficiency (Hepatoerythropoietic Porphyria) in Epstein-Barr Virus-Transformed B-Cell Lines by Retrovirus-Mediated Gene Transfer: Fluorescence-Based Selection of Transduced Cells
46. In vitro comparative analysis of Circulating Tumour Cells detection in liquid biopsy for the diagnosis of pancreatic adenocarcinoma
47. MYB-GATA1fusion promotes basophilic leukaemia: involvement of interleukin-33 and nerve growth factor receptors
48. Antisense Oligonucleotide-Based Therapy in Human Erythropoietic Protoporphyria
49. Metastasis suppressor NM23 limits oxidative stress in mammals by preventing activation of stress‐activated protein kinases/JNKs through its nucleoside diphosphate kinase activity
50. Molecular alterations and tumor suppressive function of the DUSP22 (Dual Specificity Phosphatase 22) gene in peripheral T-cell lymphoma subtypes
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.